| Centro de Investigaciones y Publicaciones Farmacéuticas |
|
|
|
Resultados
del seguimiento farmacoterapéutico en una farmacia comunitaria |
||
|
Comités editorial y científico
|
Results
of pharmacotherapy follow-up in a community pharmacy |
|
| Seguimiento Farmacoterapéutico 2004; 2(3): 189-194 | ||
| Victoria VAZQUEZ, Juán CHACÓN, José ESPEJO, María José FAUS | ||
| Resumen | ||
La Atención
Farmacéutica surge como respuesta a una necesidad social, basada
en obtener el máximo beneficio de la farmacoterapia de los pacientes,
requisito para una atención sanitaria de calidad. |
||
Palabras clave: Atención Farmacéutica. Seguimiento Farmacoterapéutico. Problemas Relacionados con los Medicamentos.
|
||
| Abstract | ||
| Pharmaceutical
care appears as a reply to a societal necessity based on obtaining the
maximum benefit from therapy in patients, as a prerequisite for a high
quality healthcare. Objectives: 1) To assess the efficacy of the Dader Method for patient pharmacotherapy follow-up. 2) To determine the capability to provide pharmacotherapy follow-up with current pharmacy structure. 3) to Determine difficulties encountered to provide this service. Method: Retrospective study from Nov-2001 to Nov-2003 in a community pharmacy in Chiclana de la Frontera (Cadiz-Spain). 50 patients under pharmacotherapy follow-up by the Dader Method were analyzed. Results: A total of 125 clinical interventions were made on patients. Most of intervened drug therapy problems (DTP) were type 5, 3, and 1 respectively. 20.8% of DTP were caused by non-compliance. 85.6% of interventions were accepted and 81.6% of health problems were resolved. Communication way more commonly used was written pharmacist-patient-physician. Conclusions: The Dader Method is efficacy to detect, prevent and resolve DTP, and to optimize pharmacotherapy in patients. It was possible to implements it in a community pharmacy with current structure. There exist some difficulties that diminished quality to pharmacotherapy follow-up. |
||
Keywords: Pharmaceutical Care. Pharmacotherapy follow-up. Drug therapy problems |
||
| © CIPF (Centro de investigaciones y Publicaciones Farmacéuticas) |